Board of Governors
CancerLinQ is governed by a volunteer Board of Governors elected by its sole member, the American Society of Clinical Oncology. The CancerLinQ Chief Executive Officer serves on the Board as well. Board members are not paid for their service, although they receive reimbursement for direct expenses related to the conduct of their Board duties.
View the Disclosures for the Board of Governors below each individual’s name. Please direct any questions related to Board members' disclosures to COI@asco.org.
-
Clifford A. Hudis, MD, FACP, FASCO, CEO, Chair
ASCO
View Disclosure
-
Ronald Andrews
OncoCyte
View Disclosure
-
Howard Burris III, MD, FACP, FASCO
Sarah Cannon
View Disclosure
-
Allen S. Lichter, MD, FASCO
Past ASCO CEO
View Disclosure
-
Aaron Sasson
Lanetix
-
Lynn Schuchter, MD, FASCO
Abramson Cancer Center, University of Pennsylvania
View Disclosure
-
Robin Zon, MD, FACP, FASCO
Michiana Hematology Oncology
View Disclosure